Skip to content
Trial Eligibility
Menu

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

NCT05287126

This study is recruiting at 12 US sites in 7 states, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to determine the safety, efficacy, and pharmacokinetics (PK) of etrasimod for the treatment of moderately to severely active ulcerative colitis in adolescents (≥ 12 years up to < 18 years of age). Participants who will complete the total 52-week treatment period will have the opportunity to continue in a Long-Term Extension (LTE) Period of up to 4 years (5 years after study enrollment).

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Ulcerative Colitis

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
12 to 17 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Pfizer
Last updated on ClinicalTrials.gov
July 8, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 4

  • Valley View Wellness Medical Center · Garden Grove, CA
  • University of California San Francisco · San Francisco, CA
  • University of California San Francisco, · San Francisco, CA
  • University of California,San Francisco Pediatric ClinicalResearch Center (PCRC) · San Francisco, CA

Florida · 1

  • Arnold Palmer Hospital - Center for Digestive Health and Nutrition · Orlando, FL

Illinois · 1

  • University of Chicago Medical Center · Chicago, IL

Massachusetts · 1

  • Boston Children's Hospital · Boston, MA

Michigan · 2

  • William Beaumont Hospital/Corewell Health - East · Royal Oak, MI
  • William Beaumont Hospitals Reference Laboratory · Royal Oak, MI

Ohio · 2

  • University Hospitals Cleveland Medical Center · Cleveland, OH
  • University Hospitals Cleveland Medical Center Rainbow Babies & Children's Hospital · Cleveland, OH

Texas · 1

  • ACT-Midwest G1 · Abilene, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.